Lessons From LEADER - All-round Leadership.

1 Secondary macrovascular outcome While the incidence of nonfatal MI and nonfatal stroke was numerically lower in the liraglutide arm of the LEADER trial, as compared to the placebo group, the difference did not reach statistical significance.

also in 111,027 other papers